General information about company |
|||
|---|---|---|---|
| Scrip Code | 540900 | ||
| NSE Symbol | NEWGEN | ||
| MSEI Symbol | NOTLISTED | ||
| ISIN | INE619B01017 | ||
| Name of company | NEWGEN SOFTWARE TECHNOLOGIES LIMITED | ||
| Type of company | Main Board | ||
| Class of security | Equity | ||
| Date of start of financial year | 01-Apr-2025 | ||
| Date of end of financial year | 31-Mar-2026 | ||
| Date of board meeting when results were approved | 17-Jul-2025 | ||
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 11-Jul-2025 | ||
| Description of presentation currency | INR (in Actuals) | ||
| Reporting Type | Quarterly | ||
| Reporting Quarter | First quarter | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Whether results are audited or unaudited for the quarter ended | Unaudited | ||
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |||
| Segment Reporting | Geographical | ||
| Description of single segment | |||
| Start date and time of board meeting | 17-Jul-2025 12:20:00 | ||
| End date and time of board meeting | 17-Jul-2025 12:30:00 | ||
| Whether cash flow statement is applicable on company | |||
| Type of cash flow statement | |||
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable | ||
Financial Results Ind-AS |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Unaudited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Income | ||
| Revenue from operations | 3206563000 | ||
| Other income | 293871000 | ||
| Total income | 3500434000 | ||
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | |
| (b) | Purchases of stock-in-trade | 0 | |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | |
| (d) | Employee benefit expense | 1815115000 | |
| (e) | Finance costs | 12204000 | |
| (f) | Depreciation, depletion and amortisation expense | 90594000 | |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 941453000 | 941453000 |
| Total other expenses | 941453000 | ||
| Total expenses | 2859366000 | ||
| 3 | Total profit before exceptional items and tax | 641068000 | |
| 4 | Exceptional items | 0 | |
| 5 | Total profit before tax | 641068000 | |
| 6 | Tax expense | ||
| 7 | Current tax | 151925000 | |
| 8 | Deferred tax | -8063000 | |
| 9 | Total tax expenses | 143862000 | |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | |
| 11 | Net Profit Loss for the period from continuing operations | 497206000 | |
| 12 | Profit (loss) from discontinued operations before tax | 0 | |
| 13 | Tax expense of discontinued operations | 0 | |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | |
| 16 | Total profit (loss) for period | 497206000 | |
| 17 | Other comprehensive income net of taxes | 30228000 | |
| 18 | Total Comprehensive Income for the period | 527434000 | |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 497206000 | ||
| Total profit or loss, attributable to non-controlling interests | 0 | ||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 30228000 | ||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 527434000 | ||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1404258000 | ||
| Face value of equity share capital | 10 | ||
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 3.55 | ||
| Diluted earnings (loss) per share from continuing operations | 3.45 | ||
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | ||
| Diluted earnings (loss) per share from discontinued operations | 0 | ||
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 3.55 | ||
| Diluted earnings (loss) per share from continuing and discontinued operations | 3.45 | ||
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
Disclosure of notes on financial results |
|||
|---|---|---|---|
| Textual Information(1) | 1. The above financial results for the quarter ended 30 June 2025 were reviewed by the Audit Committee in the meeting held on 17 July 2025 and approved by the Board of Directors in their meeting held on 17 July 2025. Standalone and Consolidated financial results of the Company for the quarter ended 30 June 2025 are prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and relevant rules thereunder. The company has complied with the guidelines issued by Securities & Exchange Board of India (SEBI) to the extent applicable. n2. The auditors have carried out limited review of Standalone and Consolidated results of the Company for the quarter ended 30 June 2025. There are no qualifications in the Auditor's review report on these financial results. The figures for the quarter ended 31 March 2025 are the balancing figures between the audited figures for full financial year up to 31 March 2025 and the unaudited year-to-date figures up to the nine months ended 31 December 2024 which were subjected to limited review. n3. The Board of Directors in their meeting held on 2 May 2025 recommended a dividend of INR 5.00 per equity share for the financial year ended 31 March 2025. The payment is subject to approval of shareholders at the ensuing Annual General Meeting. n4. During the quarter ended 30 June 2025, the Nomination & Remuneration Committee has granted 93,300 options to its employees under Newgen ESOP Scheme 2022 on 1 May 2025. n5. Previous periods/years figures have been regrouped/reclassified wherever necessary to correspond with the current period/year classification/disclosure, which are not considered material to these financial results. n | ||
Remarks |
|
|---|---|
| Debt equity ratio | |
| Debt service coverage ratio | |
| Interest service coverage ratio | |
Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Apr-2025 | ||||||
| Date of end of reporting period | 30-Jun-2025 | ||||||
| Whether accounts are audited or unaudited | Unaudited | ||||||
| Nature of report standalone or consolidated | Consolidated | ||||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | India | 953479000 | 953479000 | ||||
| 2 | EMEA | 1033710000 | 1033710000 | ||||
| 3 | APAC | 499078000 | 499078000 | ||||
| 4 | USA | 720296000 | 720296000 | ||||
| Total Segment Revenue | 3206563000 | ||||||
| Less: Inter segment revenue | 0 | 0 | |||||
| Revenue from operations | 3206563000 | ||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | India | 101292000 | 101292000 | ||||
| 2 | EMEA | 168193000 | 168193000 | ||||
| 3 | APAC | 83612000 | 83612000 | ||||
| 4 | USA | 99509000 | 99509000 | ||||
| Total Profit before tax | 452606000 | ||||||
| i. Finance cost | 12204000 | 12204000 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | -200666000 | -200666000 | |||||
| Profit before tax | 641068000 | ||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | India | 2559449000 | 2559449000 | ||||
| 2 | EMEA | 2723875000 | 2723875000 | ||||
| 3 | APAC | 1283520000 | 1283520000 | ||||
| 4 | USA | 2019226000 | 2019226000 | ||||
| Total Segment Asset | 8586070000 | 8586070000 | |||||
| Un-allocable Assets | 12123583000 | 12123583000 | |||||
| Net Segment Asset | 20709653000 | 20709653000 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | India | 1169665000 | 1169665000 | ||||
| 2 | EMEA | 1157691000 | 1157691000 | ||||
| 3 | APAC | 672752000 | 672752000 | ||||
| 4 | USA | 1007495000 | 1007495000 | ||||
| Total Segment Liabilities | 4007603000 | 4007603000 | |||||
| Un-allocable Liabilities | 977989000 | 977989000 | |||||
| Net Segment Liabilities | 4985592000 | 4985592000 | |||||
| Disclosure of notes on segments | Textual Information(2) | ||||||
Text Block |
|
|---|---|
| Textual Information(2) | Note :- na) Unallocated assets, liabilities, revenue and expenses : nCertain assets, liabilities, revenue and expenses are not specifically allocable to individual segments as the underlying services are used interchangeably. The Company believes that it is not practicable to provide segment disclosures relating to such assets, liabilities, revenue and expenses and accordingly such assets, liabilities, revenue and expenses are separately disclosed as ‘unallocated’. |
Other Comprehensive Income |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Apr-2025 | |
| B | Date of end of reporting period | 30-Jun-2025 | |
| C | Whether results are audited or unaudited | Unaudited | |
| D | Nature of report standalone or consolidated | Consolidated | |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Re-measurement gains / (losses) on defined benefit plans | -2738000 | -2738000 |
| Total Amount of items that will not be reclassified to profit and loss | -2738000 | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -957000 | |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Debt instruments through other comprehensive income - net change in fair value | -1994000 | -1994000 |
| 2 | Exchange differences on translation of foreign operations | 33538000 | 33538000 |
| Total Amount of items that will be reclassified to profit and loss | 31544000 | ||
| 4 | Income tax relating to items that will be reclassified to profit or loss | -465000 | |
| 5 | Total Other comprehensive income | 30228000 | |